Rate this post

Willow vs Hims: Compare GLP-1 Programs & Pricing

Side-by-side Willow and Hims: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.

Willow and Hims are two established telehealth providers offering GLP-1–based weight‑management programs. This article compares Willow vs Hims to help you identify which platform aligns best with your health goals, budget, and preferred level of medical oversight.

Visit Willow
Explore Hims

Willow vs Hims: Quick Overview

Provider	Semaglutide	Tirzepatide	Promo	Membership
Willow	$299.00	$399.00	Best for Oral and Injectable	— No
Hims				—

Willow vs Hims: Medical Process & Accessibility

Willow emphasizes a streamlined telehealth intake that can be completed in minutes, followed by clinician approval of your prescription. After approval, a partnered U.S. pharmacy compounds and ships the medication directly to your door. Hims also operates fully online, but its process includes a more detailed health questionnaire and scheduled virtual follow‑ups to monitor dose adjustments over time. Both services comply with FDA regulations for compounded GLP‑1 medications and require a valid prescription from a licensed U.S. clinician.

Start with Willow

Willow vs Hims: Pricing Comparison

Willow lists a starting price of $299.00 for semaglutide and $399.00 for tirzepatide. Hims does not publicly disclose a starting price for these compounds on its main site, which means you may encounter a higher cost after a personalized quote. Because Willow’s prices are the lowest available in this side‑by‑side view, they are highlighted in bold.

Neither provider charges a recurring membership fee; Willow explicitly states there is no membership requirement. Hims’ membership model varies by program, but no mandatory fee is listed for GLP‑1 therapy at the time of writing.

Compare Hims Pricing

Willow vs Hims: Clinical Oversight & Support

Both companies give you direct access to board‑certified physicians, nurse practitioners, or physician assistants who can evaluate your eligibility for GLP‑1 therapy. Willow’s model is built for quick approval—most users receive a prescription within 24‑48 hours of completing the intake form. Hims provides a more hands‑on approach, offering regular virtual check‑ins to assess weight loss progress, side‑effects, and dose titration. This ongoing support can be valuable for patients who prefer a slower, more monitored start.

Book a Consultation with Willow

Willow vs Hims: Medication Quality & Safety

Both platforms dispense compounded semaglutide or tirzepatide from FDA‑registered pharmacies in the United States. While these formulations are not identical to brand‑name products such as Wegovy® or Mounjaro®, they contain the same active ingredients and meet strict compounding standards. Prescriptions are only issued after a clinician confirms that you have no contraindications, such as a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2.

Willow vs Hims: Customer Experience

Customer reviews consistently note Willow’s affordability and rapid onboarding as its strongest points. Users appreciate the straightforward web portal, quick shipping times, and clear pricing without hidden fees. Hims receives praise for its personalized care plans, detailed educational resources, and responsive support team that often follows up via secure messaging or video calls. Shipping timelines for both services average 5‑7 business days once the prescription is approved.

Explore Hims Reviews

Willow vs Hims: Final Verdict

If your top priority is low‑cost access to GLP‑1 therapy with a fast‑track intake, Willow is the clear winner. Its transparent pricing—$299.00 for semaglutide and $399.00 for tirzepatide—makes it an attractive option for budget‑conscious patients.

Conversely, if you value a more hands‑on clinical relationship, regular dose‑adjustment appointments, and a broader suite of wellness resources, Hims may better suit your needs, even though the exact price must be obtained through a personalized quote.

Both providers operate under U.S. telehealth regulations, employ licensed clinicians, and ship FDA‑compliant compounded medications nationwide. Your decision should balance cost, desired level of medical support, and how quickly you wish to begin treatment.

Join Willow
Get Started with Hims

Disclaimer

This article is for informational purposes only and does not constitute medical advice. ExploreProviders may receive affiliate commissions at no cost to you. Always consult a licensed clinician before beginning any medical treatment.

⭐ Editor’s Choice